Table 1.

Patient’s Characteristics

PSA concentration	PSA ≤ 10 ng/ml			10 ng/ml> PSA <20 ng/ml
		302			98
Gleason score	2	3	4	5	6	7
	4	2	25	84	223	62
TNM stage	T1c		T2a	T2b		T2c
	218		107	49		26
Risk group		LR			LR
ADT	(-)		(+)	(-)		(+)
(before SABR)	95		119	72		114

PSA, Prostate Specific Antigen; TNM, Tumor, Nodes, Metastases; ADT, Androgen Deprivation Therapy; SABR, Stereotactic Ablative Radiotherapy